Emerging Contaminants Environmental Behavior Screening and Detection

Emerging contaminants (new pollutants) such as PFAS, pharmaceuticals, endocrine disruptors, antibiotic resistance genes, and microplastics are being detected at trace levels in water, soil, air, and biota worldwide, raising concerns about long-term ecological and human health risks. Environmental behavior screening and detection combines high-resolution mass spectrometry, non-target analysis, and laboratory fate testing to identify these substances and characterize their persistence, mobility, bioaccumulation, and transformation pathways. This article outlines the sample types, testing items, analytical methods, quality assurance requirements, and typical applications of emerging contaminant screening programs.

Technical Overview

Emerging contaminants, commonly referred to as "new pollutants," are substances that have been recently identified in the environment, are not yet fully regulated, or whose environmental behavior and toxicological profiles remain poorly characterized. They are typically present at trace concentrations (ng/L to µg/L levels), persist across environmental media, and can pose chronic risks even at very low exposure levels. Unlike conventional pollutants, they require advanced analytical chemistry and systematic screening strategies for detection and prioritization.

• Per- and polyfluoroalkyl substances (PFAS), including short-chain homologues and novel substitutes such as HFPO-DA (GenX)
• Pharmaceuticals and personal care products (PPCPs), including antibiotics, analgesics, and disinfectants
• Endocrine disrupting chemicals (EDCs) such as bisphenols, phthalates, and alkylphenols
• Antibiotic residues and antibiotic resistance genes (ARGs)
• Microplastics and nanoplastics
• Novel brominated and organophosphate flame retardants
• Pesticide transformation products, disinfection by-products, siloxanes, and synthetic musks

Environmental behavior screening evaluates how these substances move and change in the environment: their emission sources, transport across water, soil, air, and biota, persistence (P), bioaccumulation (B), mobility (M), toxicity (T), and their degradation into potentially hazardous transformation products. Screening results feed directly into risk assessment frameworks such as PBT/vPvB and PMT/vPvM classification, which are increasingly used by regulators to prioritize substances for control under chemical management regulations, drinking water directives, and national new pollutant control action plans.

Testing Samples

Water Samples

Water is the primary receiving medium for most emerging contaminants. Typical matrices include surface water (rivers, lakes, estuaries), groundwater, drinking water and source water, municipal and industrial wastewater treatment plant influent and effluent, landfill leachate, stormwater runoff, and sediment pore water. Sampling programs generally follow the ISO 5667 series for water quality sampling. For PFAS investigations, field protocols must avoid fluoropolymer-containing equipment, use polypropylene or HDPE containers, and include field blanks and trip blanks to prevent cross-contamination.

Soil and Sediment Samples

Soil and sediment samples are collected from agricultural land, contaminated industrial sites, riparian zones, riverbeds, lakes, estuaries, and marine areas. Depth-profiled and composited sampling helps characterize vertical migration and historical deposition. Samples are typically transported cold (4°C) or frozen, freeze-dried, homogenized, and sieved prior to extraction to ensure representative results for sorbed hydrophobic contaminants.

Air and Particulate Matter Samples

Atmospheric monitoring targets semi-volatile organic contaminants on PM2.5/PM10 filters, gaseous-phase compounds captured on polyurethane foam (PUF) cartridges, indoor air and settled dust, and stack or fugitive emissions from industrial facilities. Air sampling supports assessment of long-range atmospheric transport, a key criterion for identifying persistent organic pollutant (POP)-like behavior.

Biota and Human Specimens

Biological samples include fish, bivalves, benthic invertebrates, bird eggs, and plant tissues, which are used to evaluate bioaccumulation and trophic transfer. Human biomonitoring specimens—blood, serum, urine, and breast milk—are analyzed to assess internal exposure in epidemiological and public health studies. Human sample handling requires ethical approval, informed consent, and strict chain-of-custody procedures.

Solid Waste, Sludge, and Product Samples

Sewage sludge, compost, incineration residues, electronic waste, food contact materials, textiles, coatings, and consumer products are screened to identify emission sources at the origin of the pollution chain and to support product stewardship and material compliance programs.

Testing Items

Substance Classes

• PFAS panel: legacy and short-chain carboxylates and sulfonates (PFOA, PFOS, PFHxS, PFBA, PFBS), precursors (FTOHs, FOSAs, polyfluorinated telomers), and alternatives such as HFPO-DA and ADONA
• Pharmaceuticals: sulfonamides, quinolones, tetracyclines, macrolides, beta-blockers, lipid regulators, psychiatric drugs, and non-steroidal anti-inflammatory drugs
• Endocrine disruptors: bisphenol A and analogues, phthalate and terephthalate esters, nonylphenol and octylphenol ethoxylates, parabens, and natural and synthetic steroids
• Antibiotic resistance genes: sul, tet, erm, qnr, and bla families, plus the integron marker intI1, quantified by qPCR or digital PCR
• Microplastics and nanoplastics: abundance, particle size distribution, polymer identification, and morphology
• Flame retardants, current-use pesticides and their metabolites, disinfection by-products, cyclic siloxanes, and synthetic musks

Environmental Behavior and Fate Parameters

• Persistence: ready and inherent biodegradability, simulation half-lives in water, sediment, and soil, hydrolysis and photolysis rates
• Bioaccumulation: bioconcentration factor (BCF), bioaccumulation factor (BAF), biomagnification factor (BMF), and n-octanol/water partition coefficient (log Kow)
• Mobility: organic carbon/water partition coefficient (log Koc), soil column leaching behavior, and groundwater transport potential
• Toxicity: acute and chronic ecotoxicity using algae, daphnia, and fish embryo assays, endocrine activity screening (e.g., ER/AR reporter assays), genotoxicity and cytotoxicity tests
• Transformation product identification and mass balance in biotic and abiotic degradation studies

Testing Methods

Sample Preparation

Trace-level analysis demands rigorous extraction and clean-up. Common techniques include solid-phase extraction (SPE) with polymeric or weak-anion-exchange cartridges for aqueous PFAS and pharmaceuticals, QuEChERS and accelerated solvent extraction for soils, sediments, and biota, gel permeation clean-up to remove lipids from tissue samples, and density separation combined with oxidative digestion for microplastics. Isotope-labeled internal standards are added prior to extraction to correct for matrix effects and recovery losses.

Instrumental Analysis

• UHPLC-MS/MS (triple quadrupole) for targeted quantification of PFAS, PPCPs, EDCs, and pesticides at ng/L to pg/L levels, consistent with methods such as ASTM D7979 for PFAS
• GC-MS/MS for volatile and semi-volatile compounds, including flame retardants, siloxanes, musks, and pesticide residues
• LC-HRMS and GC-HRMS (Q-TOF, Orbitrap) for suspect and non-target screening and unknown identification
• Pyrolysis-GC-MS and FTIR/Raman microspectroscopy for microplastic polymer identification and quantification
• Real-time qPCR and droplet digital PCR for antibiotic resistance genes
• ICP-MS for organometallic and metalloid contaminants, including organotin compounds

Suspect and Non-Target Screening

Because thousands of potential contaminants cannot all be covered by targeted methods, suspect screening and non-target analysis (NTA) are essential. A typical workflow includes broad-scope HRMS acquisition in full-scan and data-dependent MS/MS modes, feature extraction and blank subtraction, formula prediction, comparison against spectral libraries and databases, retention behavior prediction, diagnostic fragment-ion confirmation, and semi-quantification using suitable surrogate standards. Effect-directed analysis (EDA) can further couple chemical fractionation with bioassays to isolate causally active toxicants in complex samples.

Environmental Fate Testing

Laboratory fate studies follow internationally recognized test guidelines to generate behavior data for risk assessment. These include ready biodegradability tests, water-sediment and soil simulation studies to derive degradation half-lives (DT50), direct and indirect photolysis tests, bioconcentration studies with aquatic organisms, and adsorption-desorption screening for mobility assessment. The resulting parameters support PMT/vPvM classification and multi-media environmental fate modeling.

Quality Assurance and Validation

All methods are validated in accredited third-party laboratories operating to ISO/IEC 17025, with defined linearity, recovery (typically 70–130%), precision, matrix effect evaluation, and method detection limits. Quality controls include procedural blanks, field blanks, matrix spikes, duplicate samples, continuing calibration verification, and participation in interlaboratory proficiency testing. Reporting includes full data packages with uncertainty statements and flagging of results near detection limits.

Applications

• Regulatory prioritization and new pollutant control action plans, including candidate listing under POPs conventions and chemical registration frameworks
• Drinking water source protection and compliance with drinking water quality standards such as GB 5749 and the associated GB/T 5750 analytical methods
• Industrial wastewater discharge monitoring for the chemical, pharmaceutical, textile, electroplating, semiconductor, and paper-making sectors
• Performance evaluation of wastewater treatment plants and advanced treatment processes (ozone, activated carbon, membrane filtration)
• Contaminated site investigation, risk assessment, and remediation verification for soil and groundwater at industrial and landfill sites
• Product stewardship, green chemistry substitution support, and supply chain material screening
• Academic research, environmental epidemiology, and human biomonitoring programs

FAQ

What is the difference between targeted analysis and non-target screening?

Targeted analysis quantifies a pre-defined list of compounds using triple-quadrupole MS/MS with high sensitivity and quantitative accuracy. Non-target screening uses high-resolution mass spectrometry to detect unknown or unexpected substances without prior compound selection, providing putative identification that can subsequently be confirmed and quantified through method development.

What detection limits can be achieved?

For most PFAS, pharmaceuticals, and endocrine disruptors in water, method quantification limits in the range of 0.1–10 ng/L are achievable with state-of-the-art LC-MS/MS instrumentation. Soil, sediment, and tissue samples typically achieve limits in the range of 0.01–1 µg/kg depending on the matrix and compound properties.

What are PMT and vPvM criteria?

PMT refers to persistent, mobile, and toxic substances, while vPvM refers to very persistent and very mobile substances. These criteria identify chemicals that resist degradation and can travel through soil into groundwater and drinking water supplies, and they are increasingly used alongside traditional PBT assessment to prioritize emerging contaminants for regulatory control.

What precautions are needed when sampling for PFAS?

PFAS sampling requires strict contamination control: fluoropolymer-free equipment and containers, no water-repellent clothing or PTFE-based materials during sampling, pre-screened field gear, dedicated nitrile gloves, and thorough field and trip blanks at a higher frequency than conventional programs.

How long does a screening and detection project take?

Targeted analysis of a standard compound list in water samples is typically completed within two to four weeks. Projects involving non-target screening, unknown identification, or laboratory fate studies require additional time for data processing, confirmation experiments, and reporting, and are scoped according to the study design.